The commission's move follows support from the UK government for a switch to open access and recent news that the European medicines regulator will open its data vaults to allow independent researchers to scrutinize results from drug companies' trials.
"The EU's decision to adopt a similar policy to that of the UK will mean that the transition time from subscription-based to open-access publishing will be substantially reduced," Professor Adam Tickell, who was involved in a recent UK government-commissioned report on the issue, told Reuters.
Tickell, of the University of Birmingham, predicted a rapid and substantial reduction in the cost of subscriptions, adding: "With the support of the EU, UK government and major charities, such as the Wellcome Trust, open access to research findings will soon be a reality."
Reed Elsevier was not available for comment. ($1 = 0.8170 euros)
(Editing by David Goodman)
- Link this
- Share this
- Digg this
- Email
- Reprints
0 comments:
Post a Comment